Wordt geladen...
Emerging treatment options for short bowel syndrome: potential role of teduglutide
INTRODUCTION: Current medical management of short bowel syndrome (SBS) involves the use of lifelong parenteral nutrition (PN). Glucagon-like peptide-2 (GLP-2), an important intestinotrophic growth factor has been shown to increase intestinal absorption in SBS through augmentation of post-resection i...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3190286/ https://ncbi.nlm.nih.gov/pubmed/22016579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S13906 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|